Uppsala University

Overview

The Biopharmaceuticals Master’s programme at Uppsala University is a comprehensive two-year course designed to guide students through the complete development pathway of biologic medicines. From molecular design and manufacturing to preclinical and clinical evaluation, this programme provides a robust foundation in the biopharmaceutical field.

Students will develop practical and analytical skills in various critical areas, including recombinant protein development, proteomics, pharmacokinetics, pharmacodynamics, and in silico modelling, all supported by research-active faculty at Uppsala University.

What you'll study

The curriculum is structured to encompass the entire biopharmaceutical life cycle, integrating core scientific courses with development, modelling, and regulatory aspects. Key topics include:

• Biopharmaceuticals
• Biologics
• Life cycle analysis of Biopharmaceuticals
• Pharmacokinetics and pharmacodynamics of biologics
• Pharmaceutical protein drug development
• Development of biologicals
• Proteomics for drug development
• Computer-based pharmaceutical modelling

Capstone / thesis: The programme includes a Master’s thesis component, providing students with the opportunity to conduct in-depth research in their area of interest.

Entry requirements

Applicants are required to hold a Bachelor’s degree (or equivalent to a Swedish Kandidatexamen) from an internationally recognised institution. Additionally, candidates must have completed at least 90 credits in one or more of the following disciplines: pharmaceutical sciences, cell biology, biotechnology, physiology, biomedicine, chemistry, or biology.

Selection: Admission is based on a holistic review of academic records and a statement of purpose (approximately one page).

GRE/GMAT/GPA: There is no specified cut-off for GRE/GMAT or GPA for this programme.

Career prospects

Graduates of the Biopharmaceuticals Master’s programme can expect to find diverse career opportunities in the pharmaceutical and biotechnology sectors. With comprehensive training in biopharmaceutical development and regulation, alumni are well-prepared to take on roles in research and development, quality assurance, regulatory affairs, and clinical trials, among others.

Furthermore, after completing their Master’s degree, students may be eligible to apply for a residence permit for work in Sweden, allowing them to gain valuable professional experience in the field.